[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Celltrion Inc.
Celltrion and Fresenius Kabi launch denosumab biosimilars, expanding treatment options. Positive sentiment is high due to FDA approvals and partnerships.
About Celltrion Inc.
Celltrion Inc. is a South Korean biopharmaceutical company.
Insights #
- Celltrion Inc. mentions is at XXX which is XXX% higher than it's daily average.
- Celltrion Inc. creators is at XX which is XXX% higher than it's daily average.
- Celltrion Inc. creators is up XXXXXX% from the previous X months.
- Celltrion Inc. engagements is up XXXXX% from the previous X months.
- Celltrion Inc. mentions is up XXXXX% from the previous week.
- Celltrion Inc. Creators hit a high of XX for the day
- Celltrion Inc. Creators hit an all time of XX for the day
- Celltrion Inc. Mentions hit a high of XXX for the day
- Celltrion Inc. Mentions hit an all time of XXX for the day
Price: $ #
Price 24-Hour Chart Data
The price is expected to increase due to positive news around FDA approval, high sentiment, and Celltrion Holdings securing fresh funding, despite a lack of current market cap data.
1-Year High: $XXXXXXX on 2024-07-29
1-Year Low: $XXXXXXX on 2025-05-12
AltRank: undefined #
AltRank 24-Hour Chart Data
Celltrion Inc. is currently AltRank #undefined based on combined combined social and market metrics
Daily Average: XXX
1-Year High: XXXXX on 2024-07-25
1-Year Low: XXX on 2025-02-26
Galaxy Score: X #
Galaxy Score 24-Hour Chart Data
Current Value: X
Daily Average: XX
1-Year High: XX on 2024-11-15
1-Year Low: X on 2025-07-23
Engagements: XXXXXX #
Engagements 24-Hour Chart Data
Current Value: XXXXXX
Daily Average: XXXXX
1 Week: XXXXXX +13%
1 Month: XXXXXXX +21%
6 Months: XXXXXXX +74%
1 Year: XXXXXXX -XX%
1-Year High: XXXXXX on 2025-06-08
1-Year Low: X on 2024-08-11
| Social Network | X | YouTube | TikTok | News | |
|---|---|---|---|---|---|
| Engagements | XXXXXX | XX | XXX | XXX | XX |
Mentions: XXX #
Mentions 24-Hour Chart Data
Current Value: XXX
Daily Average: XX
1 Week: XXX +23%
1 Month: XXX +22%
6 Months: XXX +255%
1 Year: XXX +357%
1-Year High: XXX on 2025-07-23
1-Year Low: X on 2024-07-30
| Social Network | X | YouTube | TikTok | News | |
|---|---|---|---|---|---|
| Mentions | XX | XX | XX | X | X |
Creators: XX #
Creators 24-Hour Chart Data
XX unique social accounts have posts mentioning Celltrion Inc. in the last XX hours which is up XX% from XX in the previous XX hours
Daily Average: XX
1 Week: XXX +23%
1 Month: XXX +26%
6 Months: XXX +245%
1 Year: XXX +134%
1-Year High: XX on 2025-07-23
1-Year Low: X on 2024-07-30
The most influential creators that mention Celltrion Inc. in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @boogeymantradez | X | XXXXX | X | XXXXXX |
Sentiment: XX% #
Sentiment 24-Hour Chart Data
Current Value: XX%
Daily Average: XX%
1 Week: XXX% no change
1 Month: XXX% no change
6 Months: XXX% no change
1 Year: XXX% no change
1-Year High: XXX% on 2024-08-25
1-Year Low: XX% on 2024-11-19
Most Supportive Themes
- FDA Approval: (30%) Celltrion's Yuflyma gains FDA interchangeability, expanding market potential.
- US Biosimilar Expansion: (20%) Changes in US drug pricing could increase access to affordable medicines.
- Partnership With Abpro: (15%) Celltrion is investing and partnering with Abpro.
Most Critical Themes
- Engagement Decline & Negative Sentiment: (16%) Social media interest is declining, with a decrease in engagement.
Network engagement breakdown:
| Network | Positive | % | Neutral | % | Negative | % |
|---|---|---|---|---|---|---|
| X | XXXXXX | XX% | XXXXXX | XX% | X | X% |
| XX | X% | XX | X% | X | X% | |
| YouTube | XXX | X% | XXX | X% | X | X% |
| TikTok | XXX | X% | XXX | X% | X | X% |
| News | X | X% | X | X% | X | X% |
| Total | XXXXXX | XX% | XXXXXX | XX% | X | X% |
Market Cap: $undefined #
Market Cap 24-Hour Chart Data
Current Value: $undefined
Daily Average: $XXXXXXXXXXXXXXXXXX
1-Year High: $XXXXXXXXXXXXXXXXXX on 2024-08-09
1-Year Low: $XXXXXXXXXXXXXXXXXX on 2024-11-13
Top assets mentioned In the posts about Celltrion Inc. in the last XX hours
LOBO•THE•WOLF•PUP (LOBO) AbbVie Inc (ABBV) Merck & Co., Inc. (MRK) Adappter Token (ADP) Automatic Data Processing Inc (ADP) Abbott Laboratories (ABT) Pfizer, Inc. (PFE) Microsoft Corp. (MSFT) Johnson & Johnson (JNJ)
Top topics mentioned In the posts about Celltrion Inc. in the last XX hours
$abp, united states, stocks, korea, coins healthcare, hyundai, $hcwb, $gsiw, money, stocks healthcare, $005490ks, dna, south korea, $gpus, $jyd, $lobo, $175b, $091990kq, skincare, ipo, ind, $035420ks, fisher, $003550ks, lg, insider, discount, lobo, shin, dermatology, $520m, xdc, samsung, instagram, blog, coins ai, $207940ks, governance, $abbv, marks, seoul, investment, $105560ks, $034020ks, $000150ks, $012450ks, the worlds, agencies, laura, alot, $ints, $mrk, btc eth, #eth, $032640ks, $251270ks, $3591t, loaded, $adp, automatic data processing, thailand, longterm, artificial, malik, homes, abbott laboratories, sim, wrapped bitcoin, hyundai motor, amzn, $pony, $002790ks, $090430ks, pdrn, acquisition, #fyp, telehealth, $pfe, stocks defense, told, $bslk, $abve, $wint, foryoupage, #foryoupage, ang, pag, unboxing, teva, capabilities, jersey, #ai, $009830ks, $000880ks, grand theft auto, youtube, $srt3de, $srtde, dominance, listing
Top Social Posts #
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"$ABP DD Better than any sub .30. Theyll chase it over .30 again"
@greatstockpicks on X 2025-07-23 15:34:54 UTC 79.8K followers, 6119 engagements
"@greatstockpicks Just wait. They are fully funded up to XXXX billion. Also take in celltrion purchased X million shares of the company at 10$"
@JosephGatti on X 2025-07-23 15:33:59 UTC XXX followers, 6587 engagements
"$ABP love this one because they have a big hitter backing them in Celltrion. Yes its preclinical. But this is Billions with a B and fully funded. $INTS alot more developed in Ph.3 with a data readout coming in months . Partnered with Merck and Bristol Meyers Squibb. One of them will go IMO. I like both"
@boogeymantradez on X 2025-07-23 14:38:05 UTC 3905 followers, 4021 engagements
".@Fresenius Kabi and Celltrion Launch Prolia / Xgeva (denosumab) Biosimilars Conexxence / Bomyntra and Stoboclo / Osenvelt"
@ISTPLifeScience on X 2025-07-23 12:45:54 UTC 1238 followers, XX engagements